XML 111 R96.htm IDEA: XBRL DOCUMENT v3.22.1
Net Income (Loss) Per Share - Narrative (Details) - $ / shares
1 Months Ended 7 Months Ended 12 Months Ended
Dec. 07, 2021
Mar. 31, 2022
Dec. 31, 2020
Dec. 31, 2021
Feb. 11, 2021
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]          
Options outstanding (in shares)     0 482,000  
Options, exercise price (usd per share)       $ 9.99  
Exercise price (usd per shares)       $ 11.50  
Debt conversion, converted instrument, shares issued (in shares) 17,391,304     17,391,304  
Debt instrument, convertible, conversion price (in usd per shares) $ 11.50     $ 11.50  
Antidilutive shares (in shares)     0    
Written put options          
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]          
Number of securities called by warrant (in shares)       9,952,803  
Exercise price (usd per shares)       $ 10.15  
Written put options | Subsequent Event          
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]          
Stock repurchased (in shares)   9,952,803      
Restricted Stock Units (RSUs)          
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]          
Shares outstanding (in shares)       403,300  
Performance Shares          
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]          
Shares outstanding (in shares)       150,000  
Private warrants          
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]          
Number of securities called by warrant (in shares)       366,533  
Exercise price (usd per shares) $ 11.50     $ 11.50  
Public Warrants          
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]          
Number of securities called by warrant (in shares)       11,959,939 1
Exercise price (usd per shares)         $ 11.50